![]()
Mckesson Corporation announced earnings per share of $-5.59 and Sales of $53.62 billions in the forth quarter 2018, Company's slipped into loss per share, versus $16.65 eps, earned in the same quarter a year ago, although Mckesson Corporation saw it's Sales rise by 2.14 % in the same period.
In comparison to previous quarter eps fell from $4.33 per share and Sales decreased by
-3.71 % from $53.62 billions.
Mckesson Corporation said it's sales growth was driven by U.S. Healthcare direct distribution or services segment up 15.52% Pharmaceutical Solutions segment up 9.44% Medical-Surgical Solutions segment up 2.81%, while sales in Canada distribution or services segment fell -19.78%.
For the forth quarter 2018 Mckesson Corporation logged net loss of $
-1,085 million, instead of net income of $3,536 millions achieved in the same quarter a year before.Mckesson Corporation cut it's annual earnings per share forecast by $
-2.24, now company expects eps from $9.96 to $10.46.
Looking into financial results for the fiscal year 2018, Mckesson Corporation reported Sales of $
208.36 billions and net income of $
297 millions.
Pharmacy Services & Retail Drugstore Company explained also, that Eps dropped by
-98.59 % to $0.32 per share from $22.73 in the previous fiscal year, while Sales increased by 4.95 % from $198.53 billions a year ago.
Mckesson Corporation is expected to report next financial results on July 30, 2018.
